167 related articles for article (PubMed ID: 28385068)
1. Transforming growth factor 15 increased in severe aplastic anemia patients.
Shao Y; Wang H; Liu C; Cao Q; Fu R; Wang H; Wang T; Qi W; Shao Z
Hematology; 2017 Oct; 22(9):548-553. PubMed ID: 28385068
[TBL] [Abstract][Full Text] [Related]
2. Erythropoiesis-driven regulation of hepcidin in human red cell disorders is better reflected through concentrations of soluble transferrin receptor rather than growth differentiation factor 15.
Fertrin KY; Lanaro C; Franco-Penteado CF; de Albuquerque DM; de Mello MR; Pallis FR; Bezerra MA; Hatzlhofer BL; Olbina G; Saad ST; da Silva Araújo A; Westerman M; Costa FF
Am J Hematol; 2014 Apr; 89(4):385-90. PubMed ID: 24860871
[TBL] [Abstract][Full Text] [Related]
3. Imbalance of erythropoiesis and iron metabolism in patients with thalassemia.
Huang Y; Lei Y; Liu R; Liu J; Yang G; Xiang Z; Liang Y; Lai Y
Int J Med Sci; 2019; 16(2):302-310. PubMed ID: 30745811
[No Abstract] [Full Text] [Related]
4. Growth differentiation factor 15 is related to anemia and iron metabolism in heart allograft recipients and patients with chronic heart failure.
Przybyłowski P; Wasilewski G; Bachorzewska-Gajewska H; Golabek K; Dobrzycki S; Małyszko J
Transplant Proc; 2014 Oct; 46(8):2852-5. PubMed ID: 25380934
[TBL] [Abstract][Full Text] [Related]
5. Regulation of hepcidin through GDF-15 in cancer-related anemia.
Jiang F; Yu WJ; Wang XH; Tang YT; Guo L; Jiao XY
Clin Chim Acta; 2014 Jan; 428():14-9. PubMed ID: 24384540
[TBL] [Abstract][Full Text] [Related]
6. Growth differentiation factor GDF-15 does not influence iron metabolism in stable chronic haemodialysis patients.
Li XY; Ying J; Li JH; Zhu SL; Li J; Pai P
Ann Clin Biochem; 2015 May; 52(Pt 3):399-403. PubMed ID: 25178559
[TBL] [Abstract][Full Text] [Related]
7. GDF-15, iron, and inflammation in early chronic kidney disease among elderly patients.
Lukaszyk E; Lukaszyk M; Koc-Zorawska E; Bodzenta-Lukaszyk A; Malyszko J
Int Urol Nephrol; 2016 Jun; 48(6):839-44. PubMed ID: 27043030
[TBL] [Abstract][Full Text] [Related]
8. Iron overload across the spectrum of non-transfusion-dependent thalassaemias: role of erythropoiesis, splenectomy and transfusions.
Porter JB; Cappellini MD; Kattamis A; Viprakasit V; Musallam KM; Zhu Z; Taher AT
Br J Haematol; 2017 Jan; 176(2):288-299. PubMed ID: 27917462
[TBL] [Abstract][Full Text] [Related]
9. Growth differentiation factor-15 in young sickle cell disease patients: relation to hemolysis, iron overload and vascular complications.
Tantawy AA; Adly AA; Ismail EA; Darwish YW; Ali Zedan M
Blood Cells Mol Dis; 2014 Dec; 53(4):189-93. PubMed ID: 25065856
[TBL] [Abstract][Full Text] [Related]
10. Serum iron metabolism and erythropoiesis in patients with myelodysplastic syndrome not receiving RBC transfusions.
Cui R; Gale RP; Zhu G; Xu Z; Qin T; Zhang Y; Huang G; Li B; Fang L; Zhang H; Pan L; Hu N; Qu S; Xiao Z
Leuk Res; 2014 May; 38(5):545-50. PubMed ID: 24598841
[TBL] [Abstract][Full Text] [Related]
11. Iron Status in Newly Diagnosed
Susanah S; Rakhmilla LE; Ghozali M; Trisaputra JO; Moestopo O; Sribudiani Y; Idjradinata PS; Maskoen AM
Biomed Res Int; 2021; 2021():5560319. PubMed ID: 33954177
[TBL] [Abstract][Full Text] [Related]
12. The evaluation of iron overload through hepcidin level and its related factors in myelodysplastic syndromes.
Gu S; Song X; Zhao Y; Guo J; Fei C; Xu F; Wu L; Zhang X; Zhao J; Chang C; Li X
Hematology; 2013 Sep; 18(5):286-94. PubMed ID: 23540794
[TBL] [Abstract][Full Text] [Related]
13. Acute-Phase Proteins and Iron Status in Cats with Chronic Kidney Disease.
Javard R; Grimes C; Bau-Gaudreault L; Dunn M
J Vet Intern Med; 2017 Mar; 31(2):457-464. PubMed ID: 28140480
[TBL] [Abstract][Full Text] [Related]
14. [Study on abnormal iron metabolism and iron overload in patients with aplastic anemia].
Jin P; Shi J; Li XX; Shao YQ; Nie N; Ge ML; Zhang J; Huang ZD; Huang JB; Zheng YZ
Zhonghua Xue Ye Xue Za Zhi; 2013 Oct; 34(10):877-82. PubMed ID: 24171963
[TBL] [Abstract][Full Text] [Related]
15. Erythropoiesis and Iron Homeostasis in Non-Transfusion-Dependent Thalassemia Patients with Extramedullary Hematopoiesis.
Huang Y; Liu R; Wei X; Liu J; Pan L; Yang G; Lai Y
Biomed Res Int; 2019; 2019():4504302. PubMed ID: 30834265
[TBL] [Abstract][Full Text] [Related]
16. GDF15 is related to anemia and hepcidin in kidney allograft recipients.
Malyszko J; Koc-Zorawska E; Malyszko JS; Glowinska I; Mysliwiec M; Macdougall IC
Nephron Clin Pract; 2013; 123(1-2):112-7. PubMed ID: 23797049
[TBL] [Abstract][Full Text] [Related]
17. Hepcidin and GDF-15 are potential biomarkers of iron deficiency anaemia in chronic kidney disease patients in South Africa.
Nalado AM; Olorunfemi G; Dix-Peek T; Dickens C; Khambule L; Snyman T; Paget G; Mahlangu J; Duarte R; George J; Naicker S
BMC Nephrol; 2020 Sep; 21(1):415. PubMed ID: 32993549
[TBL] [Abstract][Full Text] [Related]
18. [Colony-stimulating activities of serum from patients with severe aplastic anemia].
Zheng Y; Chu Y; Shao Z; Wang Y; Yang P; Tian Z; Tang X; Zhang J
Zhonghua Xue Ye Xue Za Zhi; 1997 Apr; 18(4):173-6. PubMed ID: 15622760
[TBL] [Abstract][Full Text] [Related]
19. [Iron chelation therapy and its influence on the alleviation of EPO resistance in MDS patients].
Zhang Y; Xiao C; Gu SC; Chang CK
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):1027-32. PubMed ID: 25130822
[TBL] [Abstract][Full Text] [Related]
20. The Growth Differentiation Factor-15 (GDF-15) levels are increased in patients with compound heterozygous sickle cell and beta-thalassemia (HbS/β
Larissi K; Politou M; Margeli A; Poziopoulos C; Flevari P; Terpos E; Papassotiriou I; Voskaridou E
Blood Cells Mol Dis; 2019 Jul; 77():137-141. PubMed ID: 31071550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]